Please login to the form below

Not currently logged in
Email:
Password:

Freeline

This page shows the latest Freeline news and features for those working in and with pharma, biotech and healthcare.

$450m diagnostics sale will fuel more Syncona biotech funding

$450m diagnostics sale will fuel more Syncona biotech funding

This will help frees up its portfolio for new investments. Since 31 March 2019, Syncona has invested £64.1min to its portfolio companies, including gene therapy companies Freeline and Gyroscope and

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Anne Prener to lead Freeline Therapeutics Anne Prener to lead Freeline Therapeutics

    She joins from Gyroscope Therapeutics to take up CEO role. London, UK-based gene therapy-focused biopharmaceutical company Freeline Therapeutics has appointed Anne Prener as its new chief executive officer. ... Frener said: “I am excited to be joining

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....